Aligos Therapeutics Inc. (ALGS)

AI Score

Unlock

4.68

0.11 (2.41%)

At close: Apr 17, 2025, 3:59 PM

4.62

-1.36%

After-hours: Apr 17, 2025, 07:58 PM EDT

Aligos Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	37M	35.33M	45.15M	24.37M	135.77M	70.43M	90.83M	78.67M	81.35M	86.44M	71.17M	104.56M	186.82M	239.73M	187.65M	200.36M	220.38M	31.82M	63.45M	-117.66M	69.56M	-90.85M
Short-Term Investments	19.94M	39.59M	49.46M	88.59M	n/a	n/a	10K	24.84M	44.48M	55.86M	88.17M	78.66M	3.92M	2.45M	3M	13.05M	23.13M	38.25M	65.44M	235.33M	48.1M	181.7M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	15.11M	492K	n/a	n/a	n/a	n/a	n/a	n/a	10.02M	n/a
Other Long-Term Assets	627K	635K	631K	625K	625K	623K	624K	632K	-2.53M	653K	616K	616K	866K	748K	1.48M	188K	377K	2.84M	235K	n/a	188K	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	5.2M	4.9M	5.03M	5.11M	5.38M	4.21M	3.4M	5.91M	7.72M	7.79M	8.34M	11.85M	13.69M	6.49M	5.99M	6.41M	6.5M	3.63M	3.33M	n/a	2.56M	n/a
Total Current Assets	62.14M	79.82M	99.57M	118.06M	141.08M	74.64M	94.24M	109.43M	133.54M	150.09M	167.69M	195.08M	204.42M	248.67M	196.64M	219.83M	250.02M	73.69M	132.23M	117.66M	120.23M	90.85M
Property-Plant & Equipment	7.33M	7.97M	8.61M	9.21M	9.82M	10.59M	11.26M	11.68M	12.51M	13.32M	14.22M	14.78M	14.97M	13.16M	13.75M	14.53M	14.91M	15.65M	16.21M	n/a	16.09M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-3.77M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	7.95M	8.6M	9.24M	9.84M	12.82M	11.21M	11.89M	12.31M	13.15M	13.98M	14.84M	15.39M	30.95M	14.4M	15.23M	14.71M	15.29M	18.49M	16.45M	n/a	26.29M	n/a
Total Assets	70.09M	88.43M	108.81M	127.9M	153.9M	85.85M	106.13M	121.74M	146.69M	164.07M	182.52M	210.47M	235.37M	263.07M	211.88M	234.54M	265.3M	92.18M	148.68M	n/a	146.52M	n/a
Account Payables	2.57M	2.74M	6.82M	2.84M	2.52M	2.94M	3.24M	2.82M	4.74M	2.93M	2.76M	3.75M	3.02M	2.6M	1.59M	2.81M	3.31M	7.68M	3.3M	n/a	3.77M	n/a
Deferred Revenue	151K	655K	1.33M	721K	1.31M	3.95M	6.95M	7.03M	9.21M	10.72M	13.13M	15.07M	7.64M	6.64M	6.81M	7.58M	7.89M	9.13M	8.81M	n/a	6.85M	n/a
Short-Term Debt	n/a	7.01M	3.35M	n/a	3.24M	3.25M	3.24M	3.15M	n/a	3.21M	2.93M	3.29M	n/a	2.78M	2.63M	2.56M	2.51M	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	6.39M	11.41M	6M	8.98M	10.58M	7.81M	9.12M	9.66M	6.36M	9.56M	9.03M	14.8M	19.07M	18.91M	15.94M	8.84M	13.89M	5.43M	4.28M	n/a	3.96M	n/a
Total Current Liabilities	21.74M	20.96M	23.56M	18.88M	23.91M	22.47M	27.23M	28.08M	33.13M	30.54M	31.65M	41.36M	38.96M	34.78M	30.1M	25.23M	30.27M	19.98M	15.36M	n/a	13.82M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	72.41M	11.64M	11.54M	42.02M	30.02M	46K	n/a	n/a	n/a	133K	133K	134K	133K	267K	267K	267K	379K	198.04M	99K	n/a	185.71M	n/a
Total Long-Term Liabilities	77.33M	17.37M	18.02M	49.23M	37.92M	8.56M	9.27M	8.91M	9.66M	11.52M	13.89M	16.23M	11.68M	11.28M	12.89M	14.09M	14.99M	208.87M	11.35M	n/a	197.59M	n/a
Total Liabilities	99.07M	38.33M	41.58M	68.11M	61.82M	31.03M	36.49M	36.99M	42.79M	42.06M	45.54M	57.58M	50.64M	46.06M	42.99M	39.32M	45.26M	228.85M	26.72M	n/a	211.41M	n/a
Total Debt	8.38M	9.13M	9.84M	10.48M	11.14M	11.77M	12.41M	11.96M	12.57M	13.03M	13.44M	14.38M	14.46M	12.42M	12.53M	12.87M	13.01M	13.35M	13.71M	n/a	14.33M	n/a
Common Stock	8K	8K	8K	7K	7K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	n/a	2K	n/a	n/a	n/a
Retained Earnings	-618.01M	-535.86M	-516.6M	-521.66M	-486.8M	-458.9M	-440.86M	-422.07M	-399.12M	-377.23M	-358.61M	-338.69M	-303.07M	-265.36M	-232.23M	-202.41M	-174.74M	-140.32M	-107.02M	n/a	-66.2M	n/a
Comprehensive Income	451K	577K	494K	476K	545K	497K	497K	499K	401K	159K	50K	204K	452K	-250K	-251K	-227K	-188K	32K	150K	n/a	-115K	n/a
Shareholders Equity	-28.97M	50.1M	67.23M	59.8M	92.08M	54.82M	69.64M	84.75M	103.9M	122.01M	136.98M	152.89M	184.73M	217.01M	168.88M	195.22M	220.04M	-136.67M	121.96M	117.19M	-64.89M	86.77M
Total Investments	19.94M	39.59M	49.46M	88.59M	n/a	n/a	10K	24.84M	44.48M	55.86M	88.17M	78.66M	19.03M	2.94M	3M	13.05M	23.13M	38.25M	65.44M	235.33M	58.12M	181.7M